API Docs
All documentation Fundamental API Live (Delayed) API EOD Historical API Intraday API Real-Time (Websockets) API Financial News API Delisted Data API
Solutions
New & Popular APIs
Show all APIs Fundamental Data APIs Indices Historical Constituents API 40 000 Stock Market Logos API Forex Data APIs
Other products
Google Sheets Add-on Excel Add-on Coding Libraries (Python, R, etc) Wordpress Add-on
API Marketplace
Community
Academy 134 articles Forum Github 13 repos
Pricing
Overview Fundamentals API Earnings EOD API Sample Code Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. NASDAQ /
  3. APRE.NASDAQ

Aprea Therapeutics Inc (APRE NASDAQ) stock market data APIs

$3.262 -0.09(-2.7%) as of September 6, 2024
Price chart is built with Anychart

Aprea Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel synthetic lethality-based cancer therapeutics that targets DNA damage response pathways. Its lead product candidate is the ATRN-119 that is in Phase I clinical trials for treating advanced solid tumors. The company is also developing ATRN-1051 for the treatment of ovarian cancer; and APRE-DDRi for the treatment of advanced solid tumors. The company is headquartered in Doylestown, Pennsylvania.

Aprea Therapeutics Inc Financial Data Overview

3.35
3.262
-
3.4001
2.99
2.99-8.8465
18 197 K
5 432 K
1 276 K
-0.58
1.916
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'APRE',
Type: 'Common Stock',
Name: 'Aprea Therapeutics Inc',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG00Q6Q3K37',
ISIN: NULL,
CUSIP: NULL,
CIK: '1781983',
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: '2019-10-03',
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: 'Domestic',
IsDelisted: false,
}

Aprea Therapeutics Inc Fundamental Data is available in our Financial Data APIs

  • Net Revenue 1 276 K
  • EBITDA -14 176 494
  • Earnings Per Share -3.01
  • Income Statements
  • Balance Sheets
  • Cash flows
Fundamental data package from $59.99 See full price
Get sample
of Fundamental API Data

Get Aprea Therapeutics Inc Earnings via APIs

  • Latest Release 2024-08-12
  • EPS/Forecast -0.63

Get Aprea Therapeutics Inc End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get Aprea Therapeutics Inc latest news via APIs

Aprea Therapeutics Reports Third Quarter 2023 Financial Results and Provides a Business Update

DOYLESTOWN, Pa., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. (Nasdaq: APRE) (“Aprea”, or the “Company”), a clinical-stage biopharmaceutical company focused on precision oncol...
  • APREA THERAPEUTICS
  • EARNINGS RELEASES AND OPERATING RESULTS
  • NASDAQ:APRE

Aprea Therapeutics to Host a Key Opinion Leader (KOL) Event on its Synthetic Lethality (SL) and DNA Damage Response (DDR) Pathways

DOYLESTOWN, Pa., Oct. 24, 2023 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. (Nasdaq: APRE) (“Aprea”, or the “Company”), a clinical stage biopharmaceutical company focused on precision oncolo...
  • APREA THERAPEUTICS
  • CALENDAR OF EVENTS
  • NASDAQ:APRE
Do you have any questions?
support@eodhistoricaldata.com